These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 26362820)

  • 1. High nodal positivity rates even in good clinical responders after chemoradiation of rectal cancer: is organ preservation feasible?
    Vallam KC; Engineer R; Desouza A; Patil P; Saklani A
    Colorectal Dis; 2016 Oct; 18(10):976-982. PubMed ID: 26362820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small carcinomas involving less than one-quarter of the rectal circumference: local excision is still associated with a high risk of nodal positivity.
    Ferko A; Orhalmi J; Dusek T; Chobola M; Hovorkova E; Hadzi Nikolov D; Dolejs J
    Colorectal Dis; 2015 Oct; 17(10):876-81. PubMed ID: 25808035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nodal Disease in Rectal Cancer Patients With Complete Tumor Response After Neoadjuvant Chemoradiation: Danger Below Calm Waters.
    Baucom RB; Maguire LH; Kavalukas SL; Geiger TM; Ford MM; Muldoon RL; Hopkins MB; Hawkins AT
    Dis Colon Rectum; 2017 Dec; 60(12):1260-1266. PubMed ID: 29112561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-Term Outcome of Rectal Cancer With Clinically (EUS/MRI) Metastatic Mesorectal Lymph Nodes Treated by Neoadjuvant Chemoradiation: Role of Organ Preservation Strategies in Relation to Pathologic Response.
    Belluco C; Forlin M; Olivieri M; Cannizzaro R; Canzonieri V; Buonadonna A; Bidoli E; Matrone F; Bertola G; De Paoli A
    Ann Surg Oncol; 2016 Dec; 23(13):4302-4309. PubMed ID: 27489059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Nomogram to Predict Lymph Node Positivity Following Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer.
    Newton AD; Li J; Jeganathan AN; Mahmoud NN; Epstein AJ; Paulson EC
    Dis Colon Rectum; 2016 Aug; 59(8):710-7. PubMed ID: 27384088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stage-Dependent Frequency of Lymph Node Metastases in Patients With Rectal Carcinoma After Preoperative Chemoradiation: Results from the CAO/ARO/AIO-94 Trial and From a Comparative Prospective Evaluation With Extensive Pathological Workup.
    Sprenger T; Rothe H; Conradi LC; Beissbarth T; Kauffels A; Kitz J; Homayounfar K; Wolff H; Ströbel P; Ghadimi M; Wittekind C; Sauer R; Rödel C; Liersch T
    Dis Colon Rectum; 2016 May; 59(5):377-85. PubMed ID: 27050599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymph node size in rectal cancer following neoadjuvant chemoradiation--can we rely on radiologic nodal staging after chemoradiation?
    Perez RO; Pereira DD; Proscurshim I; Gama-Rodrigues J; Rawet V; São Julião GP; Kiss D; Cecconello I; Habr-Gama A
    Dis Colon Rectum; 2009 Jul; 52(7):1278-84. PubMed ID: 19571705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of pathological complete response rates after neoadjuvant short-course radiotherapy or chemoradiation followed by delayed surgery in locally advanced rectal cancer.
    Hoendervangers S; Couwenberg AM; Intven MPW; van Grevenstein WMU; Verkooijen HM
    Eur J Surg Oncol; 2018 Jul; 44(7):1013-1017. PubMed ID: 29650419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological characteristics predict lymph node metastases in ypT0-2 rectal cancer after chemoradiotherapy.
    Bosch SL; Vermeer TA; West NP; Swellengrebel HA; Marijnen CA; Cats A; Verhoef C; van Lijnschoten I; de Wilt JH; Rutten HJ; Nagtegaal ID
    Histopathology; 2016 Nov; 69(5):839-848. PubMed ID: 27270756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nodal staging with MRI after neoadjuvant chemo-radiotherapy for locally advanced rectal cancer: a fast and reliable method.
    Crimì F; Cabrelle G; Campi C; Schillaci A; Bao QR; Pepe A; Spolverato G; Pucciarelli S; Vernuccio F; Quaia E
    Eur Radiol; 2024 May; 34(5):3205-3214. PubMed ID: 37930408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can mesorectal lymph node excision be avoided in rectal cancer surgery?
    Rullier E; Vendrely V
    Colorectal Dis; 2011 Nov; 13 Suppl 7():37-42. PubMed ID: 22098516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fewer than 12 lymph nodes can be expected in a surgical specimen after high-dose chemoradiation therapy for rectal cancer.
    Marks JH; Valsdottir EB; Rather AA; Nweze IC; Newman DA; Chernick MR
    Dis Colon Rectum; 2010 Jul; 53(7):1023-9. PubMed ID: 20551754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoadjuvant therapy for rectal cancer: histologic response of the primary tumor predicts nodal status.
    Read TE; Andujar JE; Caushaj PF; Johnston DR; Dietz DW; Myerson RJ; Fleshman JW; Birnbaum EH; Mutch MG; Kodner IJ
    Dis Colon Rectum; 2004 Jun; 47(6):825-31. PubMed ID: 15108025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selecting stage ypT0-1N0 for locally advanced rectal cancer following preoperative chemoradiotherapy: implications for potential candidates of organ-sparing management.
    Huang SH; Chi P; Lin HM; Lu XR; Huang YW; Xu ZB; Sun YW; Ye DX; Wang XJ; Wang X
    Colorectal Dis; 2016 Oct; 18(10):989-996. PubMed ID: 26880193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional lymph node status after neoadjuvant chemoradiation of rectal cancer producing a complete or near complete rectal wall response.
    Shwaartz C; Haim N; Rosin D; Lawrence Y; Gutman M; Zmora O
    Colorectal Dis; 2015 Jul; 17(7):595-9. PubMed ID: 25605475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transanal local excision for distal rectal cancer and incomplete response to neoadjuvant chemoradiation - does baseline staging matter?
    Perez RO; Habr-Gama A; São Julião GP; Proscurshim I; Coelho AQ; Figueiredo MN; Fernandez LM; Gama-Rodrigues J
    Dis Colon Rectum; 2014 Nov; 57(11):1253-9. PubMed ID: 25285691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DWI for Assessment of Rectal Cancer Nodes After Chemoradiotherapy: Is the Absence of Nodes at DWI Proof of a Negative Nodal Status?
    van Heeswijk MM; Lambregts DM; Palm WM; Hendriks BM; Maas M; Beets GL; Beets-Tan RG
    AJR Am J Roentgenol; 2017 Mar; 208(3):W79-W84. PubMed ID: 27959622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Organ Preservation in Rectal Adenocarcinoma: a phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and total mesorectal excision or nonoperative management.
    Smith JJ; Chow OS; Gollub MJ; Nash GM; Temple LK; Weiser MR; Guillem JG; Paty PB; Avila K; Garcia-Aguilar J;
    BMC Cancer; 2015 Oct; 15():767. PubMed ID: 26497495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nodal staging in rectal cancer: why is restaging after chemoradiation more accurate than primary nodal staging?
    Heijnen LA; Maas M; Beets-Tan RG; Berkhof M; Lambregts DM; Nelemans PJ; Riedl R; Beets GL
    Int J Colorectal Dis; 2016 Jun; 31(6):1157-62. PubMed ID: 27055660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of mesorectal nodal metastases after chemoradiation for rectal cancer: results of a randomised trial: implication for subsequent local excision.
    Bujko K; Nowacki MP; Nasierowska-Guttmejer A; Kepka L; Winkler-Spytkowska B; Suwiński R; Oledzki J; Stryczyńska G; Wieczorek A; Serkies K; Rogowska D; Tokar P;
    Radiother Oncol; 2005 Sep; 76(3):234-40. PubMed ID: 16273666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.